Do you have a tip on a health story that Newsweek should be covering
Parks, Mara Martnez-Gmez, M Serra Cusid, Neda Akhlaghi and Sergio Muoz-Martnez declare that they have no conflict of interest
Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year
Furthermore, through antioxidant activity, copper peptides help neutralize free radicals and protect the skin from harmful effects, such as UV radiation and pollution
10.1177/1747493018778713 147 Sams-DoddF
Reporting headaches from GLP-1 to your doctor is essential, especially if they are paired with other side effects like vision changes, dizziness, or vomiting